Congratulations on the establishment of the First Specialist Committee on Drug Toxicology and Safety Evaluation of the Shaanxi Provincial Society of Toxicology! Zhang Le, head of Guorui Yinuo Agency, has been elected as the chairperson!
Release time:
2023-07-25 16:48
Keywords:
On the morning of July 22, 2023, The Shaanxi Provincial Society of Toxicology held its first Professional Committee on Drug Toxicology and Safety Evaluation at Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. Dr. Zhang Le, head of Guorui Yinuo, was elected as the chairperson.

Professor Shi Zhicheng, Honorary President of the Shaanxi Provincial Society of Toxicology Professor Wei Yahui, Chairman of the Board, and Associate Professor Yan Xingrong, Secretary-General, attended the meeting. Proposal. Former State Shenyang New Drug Professor Wang Jie, Director of the Center for Safety Assessment Research; Professors Cao Yongxiao, Long Jiangang, and Liu Enqi from Xi'an Jiaotong University; and Professors Hou Zheng, Li Mingkai, Ma Xue, Liu Manling, Zhou Jie, Chen Hongli, and Xin Jiajia from the Air Force Medical University of the Chinese People's Liberation Army. /Experts—including Associate Professor Zhao Pengtao and Hu Jing from Northwest University, and Section Chief Zhou Junhong from the Drug and Vaccine Inspection Center of the Shaanxi Provincial Drug Administration—participated in the online meeting.

The meeting began with Associate Professor Yan Xingrong, Secretary-General of the Shaanxi Provincial Society of Toxicology, reading out the “Shaanxi Provincial Society of Toxicology’s Approval of Guo Rui Yinuo’s Establishment.” The “Approval for the Specialized Committee on Drug Toxicology and Safety Evaluation.” Professor Wei Yahui, Executive Director of the Chinese Society of Toxicology, Executive Deputy Director of the Institute of Ecotoxicology at Northwest University, Doctoral Supervisor, and Chairman of the Shaanxi Provincial Society of Toxicology, announced the organizational structure of the specialized committee and delivered a speech. Professor Wei stated that the establishment of the Specialized Committee on Drug Toxicology and Safety Evaluation represents a significant boost in strength and expansion of membership for the Shaanxi Provincial Society of Toxicology. It also marks an attempt at deeper collaboration between the Shaanxi Provincial Society of Toxicology and enterprises, enhancing the society’s roles in science popularization and social service. At the same time, it will further improve the development quality, social influence, and service capabilities of Guorui Yinuo. Professor Wei urged the Specialized Committee on Drug Toxicology and Safety Evaluation to comply with all relevant national laws and regulations, operate legally according to the articles of association of the Shaanxi Provincial Society of Toxicology, and ensure fair compensation. He also expressed his hope that the establishment of the specialized committee would drive and promote the development of Guorui Yinuo, enabling the committee, under the leadership of the Shaanxi Provincial Society of Toxicology, to actively carry out more work and make greater contributions to society.


The Professional Committee invites Professor Wang Jie, a director of the Asian Society of Toxicology, vice-chairman of the Chinese Society of Toxicology, a “Century-Top Talent” selected by the Ministry of Science and Technology, recipient of the Special Allowance for Special Zones awarded by the State Council, and former director of the National Shenyang Center for New Drug Safety Evaluation Research. International magazine Professor Cao Yongxiao, Associate Editor of Toxicology & Applied Pharmacology, Professor of Pharmacology at the School of Medicine, Xi'an Jiaotong University, and Doctoral Supervisor, serves as a consultant. The preparatory group of the Professional Committee elected Zhang Le as the chairperson; the following members were elected: Qu Jianpeng, Long Jiangang, Liu Enqi, Li Mingkai, Zhou Jie, Yan Xingrong, and Li Zhiyuan. 7 Acting Vice Chairperson; elected by vote Standing Committee Member 12 Person, committee 60 Person, secretary 2 people.
Professor Shi Zhicheng, former Director of the Shaanxi Provincial Department of Agriculture, Director of the Institute of Ecotoxicology at Northwest University, and Honorary President of the Shaanxi Toxicology Society, conferred the Guirui Yinuo award. The “Board Member” plaque was presented to the “Specialized Committee on Drug Toxicology and Safety Evaluation.” Professor Shi expressed great appreciation and encouragement for the establishment of the specialized committee, and he hoped that Guorui Yinuo would actively respond to President Xi Jinping’s call to vigorously develop private enterprises and drive regional economic growth.


Dr. Zhang Le, the newly appointed director of the Professional Committee, delivered a speech, expressing gratitude for the trust and support from all the expert teachers. He emphasized that the role of committee director carries a heavy responsibility and mission, and that he will work side by side with all committee members, fostering unity and collaboration to establish a convenient, efficient, and reliable technical platform for new drug research and development as well as preclinical safety evaluation in Shaanxi Province’s pharmaceutical industry, thereby further enhancing... “Qin Chuang Yuan” will make greater contributions to the synergistic integration of the innovation chain and industrial chain in the life sciences sector.
Professor Cao Yongxiao delivered a message to the conference, expressing his delight at seeing the establishment of the Specialized Committee on Drug Toxicology and Safety Evaluation under the Shaanxi Provincial Society of Toxicology. Drug safety is an essential attribute of pharmaceuticals, and the safety evaluation of drugs requires both standardization and scientific rigor. An important indicator of standardization is... GLP Laboratory. Guorui Yinuo is the first institution in Shaanxi Province to obtain the National Medical Products Administration’s GLP certification approval for pharmaceuticals, marking the official entry of drug safety evaluation in Shaanxi Province into a standardized channel. The current Professional Committee boasts a large and highly qualified membership with strong technical expertise. Chairperson Zhang Le and General Manager Su Lai are among the earliest experts and key personnel in China dedicated to drug safety evaluation. Additionally, experts in drug safety evaluation from universities such as Xi’an Jiaotong University, Air Force Medical University of the Chinese People's Liberation Army, and Northwest University are also actively involved. We are confident that the Professional Committee will successfully expand and strengthen drug safety evaluation efforts, making significant contributions to preclinical drug assessment.

Zhou Junhong, Chief of the Drug and Vaccine Inspection Center of the Shaanxi Provincial Drug Administration, also attended the meeting. She introduced the scope of responsibilities of the provincial inspection center and emphasized that preclinical safety evaluation of new drugs plays a crucial role in determining whether a new drug can proceed to clinical studies, predicting the level of risks involved in clinical trials, and ultimately assessing its development value. High-quality safety evaluation work must adhere to... The GLP principles represent a consensus among regulatory authorities and new-drug research institutions across various countries. We hope that the specialized committees will leverage their professional expertise to assist the provincial drug administration in strengthening its technical capabilities and expanding its scope of operations, thereby driving and elevating the GLP research standards in our province.

Become The Establishment of the Professional Committee for Drug Toxicology and Safety Evaluation is primarily aimed at comprehensively promoting the development of our province’s biopharmaceutical industry, enhancing the level of safety evaluation research for pharmaceuticals and medical devices, facilitating the full implementation and comprehensive advancement of ICH S-series (Safety Series) guidelines both nationally and within the province, achieving full international alignment in non-clinical safety evaluation research domestically, and establishing a platform for sharing the latest advances in drug toxicology research as well as new ideas and technologies for preclinical safety evaluation of drugs—thus integrating safety evaluation with international policies and the pharmaceutical industry. High-end academic exchange platform.
Related News